Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Trust that sold millions of pounds of hospital drugs in 'unacceptable' export trade named


The NHS hospital that sold millions of pounds’ worth of hospital drugs intended for NHS use onto the export market, despite government warnings the behaviour was “unacceptable”, has been identified.

An investigation by Nursing Times’ sister publication HSJ has revealed Royal Surrey County Hospital Foundation Trust is the trust whose flirtation with the pharmaceutical export market sparked concern at the Department of Health, which believed it could “rapidly” and “immediately” create serious shortages for vital hospital drugs.

Quite simply, if product is diverted in this way it is likely to have an immediate and dramatic impact on the availability of product to treat UK patients

But despite the DH’s concern the Royal Surrey’s trading activities helped shore up its foundation trust application. By December - the month it was awarded foundation status - the trust had almost doubled its performance on the principal profit rate measure used by the regulator Monitor from 4.6 per cent to 8.3 per cent.

The trust earned £4.6m in revenue over 10 months by buying up drugs at the NHS price and selling them to a wholesaler for export, as the low value of the pound meant they could be sold at a profit. It made £300,000 profit on the sales.

It only ended the practice last month - six months after the DH branded the trading “wholly unacceptable” and said it threatened the safe supply of medicines to the NHS.

There are now more than 40 branded and generic medicines in short supply in the UK. These include Zyprexa, which is used to treat schizophrenia, and Glivec, which is used to treat advance stage leukaemia.

Health minister Mike O’Brien has called for an emergency summit to address mounting NHS drug shortages, which he said were being exacerbated by “unscrupulous” speculators who were “putting profit before patients” by selling drugs intended for NHS use abroad.

HSJ uncovered the Royal Surrey’s activities by correlating information obtained through a Freedom of Information request with the trust’s finance reports.

The foundation’s finance director Paul Biddle told HSJ: “Yes, we did see this as an opportunity to make a margin.”

“I felt we hadn’t anything to hide in this. It was openly declared when we went through assessment with Monitor. They have always encouraged trusts to be entrepreneurial.”

He said the trust had not sold any drugs that were in danger of short supply to the NHS. But the foundation refused to give HSJ a list of the drugs which were traded, saying this was “commercially sensitive”.

The foundation ceased trading in hospital drugs in January - partly due to the public concern around the impact of so called “parallel trading”, and partly due to the diminished opportunity for a profit, as the value of the euro fell from a peak of 94p in October to 86p by the end of the month.

Internal memos released to HSJ show that some time before the end of May 2009 a whistleblower from the South East region alerted the DH that a trust in the region was suspected of trading drugs for export.

As HSJ reported in January 2009, the NHS was already experiencing drug shortages as the weak pound caused cheap imports to dry up and manufacturers imposed supply quotas to prevent community pharmacists from over-ordering for export.

But in an email to the whistleblower dated 27 May 2009, the NHS Purchasing and Supply Agency’s principle pharmacist Howard Stokoe said the spread of export trading to acute hospitals was a “serious concern” due to the relatively small volumes of drugs supplied to hospitals.

Mr Stokoe wrote: “Quite simply, if product is diverted in this way it is likely to have an immediate and dramatic impact on the availability of product to treat UK patients.”

“Not only would this compromise patient care it would also be damaging for the reputations of any NHS trusts involved in this practice.”

Mr Stokoe also warned that pharmaceutical manufacturers might regard onward sales for profit as an abuse of the NHS pricing agreement - jeopardising future negotiations for NHS discounts.

That exchange of emails culminated in a letter being sent from DH chief pharmacist Keith Ridge to all hospital chief pharmacists last July which said it was “wholly unacceptable” and “irresponsible” for NHS hospitals to export drugs. However, the Royal Surrey continued to trade for six months after this.

Mr Biddle told HSJ: “We absolutely assured ourselves the drugs being supplied were freely available. There was no question of diverting drugs needed for the NHS. But because of the publicity and the fact it was a short term accountancy opportunity we saw it for only a limited period. So we stopped as of January 2010.”

A spokesman for Monitor confirmed it was aware of the Royal Surrey’s drug trading, but he said: “So long as the drug trading does not affect UK patients or the ability of the trust board to focus on their core responsibilities this is not an issue on which we would take a view.”


Readers' comments (3)

  • If there is anyone who doubts that the purpose of foundation trust status is to effect a soft privatisation of the health service let them read this article

    Unsuitable or offensive? Report this comment

  • The only people who doubt it are the uneducated or plain thick.

    The NHS as we know it is being stealthily privatised. joe public knows nothing of this and would quite rightly be outraged if they knew.

    It is a disgraceful betrayal of the public and NHS staff. Politics will wreck the will be one of the things nu labour will be remebered for....a shocking party full of middle class educated numbskulls...hellbent on selling off (commissioning) the NHS.

    Unsuitable or offensive? Report this comment

  • Everyone who works in the NHS knows that privatisation is being brought about in a truly underhanded and surreptitious manner. In 2007 I was on a march throught the centre of London with the joint unions of Unison, Unite, RCN, GMB, et al. When I got home, not one mention of this on the news. Thousands of people marching through London and nothing! Had this been a BNP or right wind Islam extreemist march then it would have been front page news of every paper, but good old NHS get nothing!
    I truly think the whole population is apathetic to the cause of the NHS and it's work force. As long as it is there for them when they need it then they don't care!
    I remeber this being said to me as a child by my uncle "You don't miss the water until the well runs dry". Well look out everyone it looks like it is "drying out time".

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.